MENS
Jyong Biotech Ltd. Ordinary Shares
$3.22
-0.34
(-9.55%)
| Exchange: | |
| Market Cap: | 244.809M |
| Shares Outstanding: | 71.567M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Biotechnology | |||||
| CEO: | Fu-Feng Kuo | |||||
| Full Time Employees: | 31 | |||||
| Address: |
|
|||||
| Website: | https://www.jyongbio.com/ |
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Click to read more…
Revenue Segmentation
EPS
Earnings Call
Income Statement
(* All numbers are in thousands)
Balance Sheet
(* All numbers are in thousands)
Cash Flow Statement
(* All numbers are in thousands)
Analyst Estimates
(* All numbers are in thousands)
